Leads Biolabs has received approval for an investigational new drug (IND) application for its PD-L1/4-1BB bispecific antibody in metastatic colorectal cancer (mCRC). The therapy is intended for microsatellite stable (MSS) or mismatch repair proficient (pMMR) mCRC, a group that represents about 95% of mCRC cases and has shown limited response to conventional immune checkpoint inhibitors. Colorectal cancer sees about 1.926 million new cases and 904,000 deaths globally each year, ranking as the third most common cancer and the second leading cause of cancer-related death.

Apple lowered its fiscal fourth-quarter 2025 revenue growth outlook to 9%–11%, below analysts’ expectations of more than 12%. China sales came in at $18.8 billion versus an expected $19.6 billion, while services revenue of $30.7 billion missed a $31.4 billion forecast. Although total revenue of $109.4 billion beat estimates, the weaker guidance raised concerns about demand for new iPhone models and momentum in Greater China, sending the stock down 7.4% in its biggest one-day drop in nearly two years.

Bajaj Finserv reported Q1 FY27 net profit of Rs 3,132 crore, up 12% year on year, while revenue from operations rose 19% to Rs 42,037 crore. Following the results, the stock jumped more than 6% in a single session. Several brokerages upgraded the stock to Buy and raised their target prices.

Advance Technoforge Limited is set to list on the BSE SME platform on August 3 at an issue price of Rs 95 per share. The stock is quoting at a 4% grey market premium, implying an estimated listing price of around Rs 99 and a potential first-day gain of about 4.21%. The IPO was subscribed 1.55 times overall.

Kering reported first-half revenue of 7.22 billion euros on July 28, up 1% year on year on a comparable basis. Second-quarter revenue rose 2% to 3.652 billion euros, marking its first quarterly growth in three years, according to 36Kr. Gucci’s second-quarter revenue fell 2%, narrowing from an 8% decline in the first quarter. The stock surged 17% on the next trading day.

Two India IPOs are heading into their final day of bidding on Monday, with MV Electrosystems seeing strong demand while Juniper Green Energy remains under-subscribed. MV Electrosystems’ Rs 290 crore offer was nearly covered by institutional investors and drew heavy retail interest, whereas Juniper Green’s Rs 1,800 crore issue has yet to be fully subscribed. Analysts flagged customer concentration risk at Juniper Green, where the top two customers contribute 86.06% of FY26 revenue.

Shadowfax Technologies posted Q1FY27 revenue of ₹1,358 crore, up 64.9% year on year and 9.8% quarter on quarter. Net profit rose 715.9% from a year earlier to a record ₹65 crore, while EBITDA margin expanded 370 basis points to 6.8%. On the back of the quarter, the logistics technology firm raised its FY27 revenue growth guidance to 38–40% from 27–30% and kept its margin targets unchanged. The company said momentum was supported by enterprise demand, more new customers, and growth in hyperlocal and ecommerce.

China’s outbound direct investment across all industries rose 3.8% year on year in the first half of 2026 to 5964.2 billion yuan. Nonfinancial ODI totaled 4530.6 billion yuan over the period. Investment in Belt and Road partner countries fell 11.1% to 1207.7 billion yuan, while newly signed overseas engineering contracts in those countries increased 11.8% to 5207.1 billion yuan.